
The Upper East Regional Health Directorate has launched its second round of the 2026 Mass Drug Administration (MDA) campaign, aiming to treat 164,525 people against onchocerciasis, commonly known as river blindness. The initiative, scheduled to run from November 15 to November 28, is a critical component of the Ghana Health Service’s strategy to eliminate the parasitic disease in the region. Health officials have identified 14 high-risk sub-districts where the risk of infection remains prevalent due to the presence of fast-flowing rivers where blackflies breed.
During the two-week campaign, trained health workers will visit households to distribute ivermectin tablets directly to eligible residents. Dr. Braimah Baba Abubakari, the Regional Director of Health, stressed the importance of achieving comprehensive treatment coverage to break the chain of transmission. According to health data, approximately 205,656 people in the region are at risk of the infection, which can lead to severe skin irritation and permanent vision loss if left untreated. The house-to-house approach is designed to ensure that the medication reaches the maximum number of people in the targeted sub-districts.
To ensure the success of the exercise, the health directorate has engaged traditional and religious leaders to assist with public education and community mobilization. While the goal is broad coverage, health workers have been instructed to exclude pregnant women and those who are severely ill from the administration. Dr. Abubakari urged the public to cooperate with health teams, noting that consistent community-wide participation is essential for the long-term goal of eradicating river blindness from the Upper East Region.